维普期刊资源整合服务平台（V6.5）

118篇 您的检索式：作者名="Creutzig"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	北京城市交通发展政策述评及对拥挤收费的讨论显示文摘中国城市交通发展政策承载了很多共同利益,包括减少空气污染与交通拥堵、提高骑车者与行人的交通安全以及改善公共汽车服务的可靠性。逐一评述北京市为达成上述事项而实施的包括公共交通、限行措施、小汽车数量调控和停车管理在内的一系列城市交通发展政策。指出北京市已实施的一系列政策还无法实现缓解交通拥堵的目标,未来可以考虑采取更加行之有效的措施,如交通拥挤收费。由此定量论证了北京市实施拥挤收费的前景及其综合效益,并探讨了实施拥挤收费的重要保障因素:决策与公平、综合配套措施、政府支持、国际经验。	Felix Creutzig Maximilian Thess 周江评 Michael Replogle 韩慧敏耿雪张绍滨	2011	城市交通2011，9，4：	7
2	Randomized trial comparing liposomal daunorubicin with idarubiein as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004显示文摘	Creutzig U Zimmermarm M Bourquin JP	2013	Blood2013，122，1：	1
3	Prostanoids in therapy of peripheral arterial occlusive disease显示文摘	Caspary L	1991	Therapie1991，46，：	1
4	Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)显示文摘	Thiede C Koch S Creutzig E	2006	Blood2006，107，10：	1
5	Pediatric acutemyeloid leukemia:international progress and future directions显示文摘	Kaspers G J L Creutzig U	2005	Leukemia2005，19，：	1
6	Definintion of a standard-risk group in children with AML显示文摘	Creutzig U Zimmermann M Ritter J	1999	Br J Haematol1999，104，：	1
7	Treat ment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials显示文摘	Creutzig U Zimmermann M Ritter J	2005	Leukemia2005，19，：	1
8	Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia(AML)显示文摘	Thiede C Koch S Creutzig E	2006	Blood2006，107，：	1
9	Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML) 显示文摘	Thiede C Koch S Creutzig E	2006	Blood2006，107，10：	1
10	Favorable out- come in infants with AML after intensive first-and second-line treatment: an AML-BFM study group report 显示文摘	Creutzig U Zimmermann M Bourquin JP	2012	Leukemia2012，26，4：	1
11	Meta -analysis of randomised controlled prostaglandin E-1 studies in peripheral arterial occlusive disease stages III and IV 显示文摘	Creutzig A	2004	Vasa-journal of vascular disease2004，33，：	1
12	Diagnosis and management of acute myeloid leukemia in children and adolescents:recommendations from an international expert panel显示文摘	Creutzig U van den Heuvel-Eibrink MM Gibson B	2012	{H}Blood2012，，16：	1
13	Prevalence and prognosticimpaet of NPM1 mutations in 1 485 adult pa- tients with acute myeloid leukemia(AML) 显示文摘	Thiede C Koch S Creutzig E	2006	Blood2006，107，10：	1
14	Idarubicin improves blast cell clearance during in duction therapy in children with AML:results of study AML-BFM 93显示文摘	Creutzig U Ritter J Zimmermann M	2001	Leukemia2001，15，：	1
15	Treatment strategies andlong term results in pediatric patients treated in four consecutiveAML -BFM trials显示文摘	Creutzig U Zimmermann M Ritter J	2005	Leukemia2005，19，12：	1
16	Imaging of malignant tumours with 99mTc-MIBI SPECT显示文摘	Muller ST Guth-Tougelides B Creutzig H	1987	J Nucl Med1987，28，：	1
17	Treatment Strategies and Long Term Results in Pediatric Patients Treated in Four Consecutive AML-BFM Trials显示文摘	Creutzig U Zimmermann M Ritter J	2005	Leukemia2005，19，12：	1
18	Im proved treatment results in high risk pediatric AML patients after intensification with high dose Ara-C and mitoxantrone:results of study AML-BFM 93显示文摘	Creutzig U Ritter J Zimmermann M	2001	J Clin Oncol2001，19，：	1
19	Meta - analysis of randomised controlled prostaglandin E -1 studies in peripheral arterial occlusive disease stages III and IV 显示文摘	Creutzig A	2004	Vasa -journal of vascular disease2004，33，：	1
20	Isolated myelosarcoma in children-update and review显示文摘	Reinhardt D Creutzig U	2002	Leuk Lymphoma2002，43，3：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示